Abstract

Cystinosis, a rare autosomal recessive lysosomal storage disease, is due to impaired transport of cystine from lysosomes. The disease results in deposition of crystals throughout the body; if untreated, it leads to failure to thrive, profound metabolic imbalance, early end-stage renal disease, thyroid failure, and multiorgan dysfunction. As this review describes, substantial progress has been made in our understanding and treatment of this disorder. The administration of cysteamine, each molecule of which can combine with a half-molecule of cystine (cysteine) to facilitate the exit of cystine from the lysosome, has greatly improved the course of the disease. In addition, the gene for cystinosis, CTNS, which…

Citation impact

690
total citations
FWCI
7.88
Percentile
100%
References
60
Citations per year

Authors

3

Topics & keywords

Keywords
  • Cystinosis
  • Cysteamine
  • Cystine
  • Lysosomal storage disease
  • Medicine
  • Failure to thrive
  • Disease
  • Lysosome
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.